Table of Contents Author Guidelines Submit a Manuscript
International Journal of Inflammation
Volume 2012, Article ID 505674, 11 pages
http://dx.doi.org/10.1155/2012/505674
Research Article

Assessment of the Microbiota in Microdissected Tissues of Crohn's Disease Patients

1Department of Morphology and Molecular Pathology, University Hospitals KULeuven, Minderbroedersstraat 12, 3000 Leuven, Belgium
2Department Research Informatics & Integrated Genomics, Janssen Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium
3Department of Gastroenterology, University Hospitals KULeuven, Herestraat 49, 3000 Leuven, Belgium

Received 18 July 2011; Revised 5 September 2011; Accepted 14 September 2011

Academic Editor: Derek Jewell

Copyright © 2012 Gert De Hertogh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. P. Hugot, M. Chamaillard, H. Zouali et al., “Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease,” Nature, vol. 411, no. 6837, pp. 599–603, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Ogura, D. K. Bonen, N. Inohara et al., “A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease,” Nature, vol. 411, no. 6837, pp. 603–606, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. D. A. van Heel, K. A. Hunt, K. King et al., “Detection of muramyl dipeptide-sensing pathway defects in patients with Crohn's disease,” Inflammatory Bowel Diseases, vol. 12, no. 7, pp. 598–605, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. D. K. Bonen and J. H. Cho, “The genetics of inflammatory bowel disease,” Gastroenterology, vol. 124, no. 2, pp. 521–536, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Lecat, J. Piette, and S. Legrand-Poels, “The protein Nod2: an innate receptor more complex than previously assumed,” Biochemical Pharmacology, vol. 80, no. 12, pp. 2021–2031, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. J. G. Magalhaes, M. T. Sorbara, S. E. Girardin, and D. J. Philpott, “What is new with Nods?” Current Opinion in Immunology, pp. 29–34, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Van Limbergen, D. C. Wilson, and J. Satsangi, “The genetics of Crohn's disease,” Annual Review of Genomics and Human Genetics, vol. 10, pp. 89–116, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. J. L. Mendoza, A. San-Pedro, E. Culebras et al., “High prevalence of viable mycobacterium avium subspecies paratuberculosis in crohn's disease,” World Journal of Gastroenterology, vol. 16, no. 36, pp. 4558–4563, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Toracchio, H. M. T. El-Zimaity, C. Urmacher, S. Katz, and D. Y. Graham, “Mycobacterium avium subspecies paratuberculosis and Crohn's disease granulomas,” Scandinavian Journal of Gastroenterology, vol. 43, no. 9, pp. 1108–1111, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. E. S. Pierce, “Where are all the Mycobacterium avium subspecies paratuberculosis in patients with crohn's disease?” PLoS Pathogens, vol. 5, no. 3, Article ID e1000234, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Martinez-Medina, A. Mora, M. Blanco et al., “Similarity and divergence among adherent-invasive Escherichia coli and extraintestinal pathogenic E. coli strains,” Journal of Clinical Microbiology, vol. 47, no. 12, pp. 3968–3979, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. G. De Hertogh, J. Aerssens, K. P. Geboes, and K. P. Geboes, “Evidence for the involvement of infectious agents in the pathogenesis of Crohn's disease,” World Journal of Gastroenterology, vol. 14, no. 6, pp. 845–852, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. C. P. Tamboli, C. Neut, P. Desreumaux, and J. F. Colombel, “Dysbiosis in inflammatory bowel disease,” Gut, vol. 53, no. 1, pp. 1–4, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Joossens, G. Huys, M. Cnockaert et al., “Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives,” Gut, vol. 60, pp. 631–637, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Swidsinski, V. Loening-Baucke, and A. Herber, “Mucosal flora in Crohn's disease and ulcerative colitis—an overview,” Journal of Physiology and Pharmacology, vol. 60, supplement 6, pp. 61–71, 2009. View at Google Scholar
  16. P. D. Scanlan, F. Shanahan, C. O'Mahony, and J. R. Marchesi, “Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease,” Journal of Clinical Microbiology, vol. 44, no. 11, pp. 3980–3988, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. J. E. Clarridge III, “Impact of 16S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases,” Clinical Microbiology Reviews, vol. 17, no. 4, pp. 840–862, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. R. B. Sartor, “Microbial influences in inflammatory bowel diseases,” Gastroenterology, vol. 134, no. 2, pp. 577–594, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Esters, M. Pierik, K. Van Steen et al., “Transmission of CARD15 (NOD2) variants within families of patients with inflammatory bowel disease,” The American Journal of Gastroenterology, vol. 99, no. 2, pp. 299–305, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Rossello-Mora and R. Amann, “The species concept for prokaryotes,” FEMS Microbiology Reviews, vol. 25, no. 1, pp. 39–67, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Stackebrandt and B. M. Goebel, “Taxonomic note: a place for DNA-DNA reassociation and 16S rRNA sequence analysis in the present species definition in bacteriology,” International Journal of Systematic Bacteriology, vol. 44, no. 4, pp. 846–849, 1994. View at Google Scholar · View at Scopus
  22. G. Garrity, J. Bell, and T. Lilburn, “Taxonomic outline of the prokaryotes,” in Bergey's Manual of Systemic Bacteriology, G. Garrity, Ed., pp. 1–401, Springer, New York, NY, USA, 2004. View at Google Scholar
  23. H. Fujita, Y. Eishi, I. Ishige et al., “Quantitative analysis of bacterial DNA from Mycobacteria spp., Bacteroides vulgatus, and Escherichia coli in tissue samples from patients with inflammatory bowel diseases,” Journal of Gastroenterology, vol. 37, no. 7, pp. 509–516, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Marteau, “Bacterial flora in inflammatory bowel disease,” Digestive Diseases, vol. 27, supplement 1, pp. 99–103, 2009. View at Google Scholar
  25. P. Ryan, M. W. Bennett, S. Aarons et al., “PCR detection of Mycobacterium paratuberculosis in Crohn's disease granulomas isolated by laser capture microdissection,” Gut, vol. 51, no. 5, pp. 665–670, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Ryan, R. G. Kelly, G. Lee et al., “Bacterial DNA within granulomas of patients with Crohn's disease—detection by laser capture microdissection and PCR,” The American Journal of Gastroenterology, vol. 99, no. 8, pp. 1539–1543, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. G. de Hertogh, J. Aerssens, R. de Hoogt et al., “Validation of 16S rDNA sequencing in microdissected bowel/biopsies from Crohn's disease patients to assess bacterial flora diversity,” Journal of Pathology, vol. 209, no. 4, pp. 532–539, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. L. A. Kulakov, M. B. McAlister, K. L. Ogden, M. J. Larkin, and J. F. O'Hanlon, “Analysis of bacteria contaminating ultrapure water in industrial systems,” Applied and Environmental Microbiology, vol. 68, no. 4, pp. 1548–1555, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. N. B. Kumar, T. T. Nostrant, and H. D. Appelman, “The histopathologic spectrum of acute self-limited colitis (acute infectious-type colitis),” The American Journal of Surgical Pathology, vol. 6, no. 6, pp. 523–529, 1982. View at Google Scholar · View at Scopus
  30. T. Gouliouris, N. M. Brown, and S. H. Aliyu, “Prevention and treatment of Clostridium difficile infection,” Clinical Medicine, vol. 11, pp. 75–79, 2011. View at Google Scholar
  31. A. Tursi and S. Papagrigoriadis, “Review article: the current and evolving treatment of colonic diverticular disease,” Alimentary Pharmacology and Therapeutics, vol. 30, no. 6, pp. 532–546, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Kawada, M. Annaka, H. Kato et al., “Evaluation of a simultaneous detection kit for the glutamate dehydrogenase antigen and toxin A/B in feces for diagnosis of Clostridium difficile infection,” Journal of Infection and Chemotherapy. In press. View at Publisher · View at Google Scholar
  33. F. Barbut, M. Monot, A. Rousseau et al., “Rapid diagnosis of Clostridium difficile infection by multiplex real-time PCR,” European Journal of Clinical Microbiology & Infectious Diseases, vol. 30, no. 10, pp. 1279–1285, 2011. View at Google Scholar
  34. M. Martinez-Medina, X. Aldeguer, F. Gonzalez-Huix, D. Acero, and L. J. Garcia-Gil, “Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis,” Inflammatory Bowel Diseases, vol. 12, no. 12, pp. 1136–1145, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Swidsinski, V. Loening-Baucke, M. Vaneechoutte, and Y. Doerffel, “Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora,” Inflammatory Bowel Diseases, vol. 14, no. 2, pp. 147–161, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Swidsinski, A. Ladhoff, A. Pernthaler et al., “Mucosal flora in inflammatory bowel disease,” Gastroenterology, vol. 122, no. 1, pp. 44–54, 2002. View at Google Scholar · View at Scopus
  37. H. Sokol, P. Seksik, J. P. Furet et al., “Low counts of faecalibacterium prausnitzii in colitis microbiota,” Inflammatory Bowel Diseases, vol. 15, no. 8, pp. 1183–1189, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. R. D. Berg, “Bacterial translocation from the gastrointestinal tract,” Trends in Microbiology, vol. 3, no. 4, pp. 149–154, 1995. View at Publisher · View at Google Scholar · View at Scopus
  39. F. Guarner and J. R. Malagelada, “Gut flora in health and disease,” The Lancet, vol. 361, no. 9356, pp. 512–519, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Balzan, C. de Almeida Quadros, R. de Cleva, B. Zilberstein, and I. Cecconello, “Bacterial translocation: overview of mechanisms and clinical impact,” Journal of Gastroenterology and Hepatology, vol. 22, no. 4, pp. 464–471, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. S. W. Huang, B. M. Hsu, S. F. Wu et al., “Water quality parameters associated with prevalence of Legionella in hot spring facility water bodies,” Water Research, vol. 44, no. 16, pp. 4805–4811, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Ferrante, G. de Hertogh, T. Hlavaty et al., “The value of myenteric plexitis to predict early postoperative Crohn's disease recurrence,” Gastroenterology, vol. 130, no. 6, pp. 1595–1606, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Sokol, V. Polin, A. Lavergne-Slove et al., “Plexitis as a predictive factor of early postoperative clinical recurrence in Crohn's disease,” Gut, vol. 58, no. 9, pp. 1218–1225, 2009. View at Publisher · View at Google Scholar · View at Scopus